Skip to content

Psilocybin administered following extinction sessions does not affect subsequent cocaine cue reinstatement in male and female rats and mice.

Veronika Pohořalá, Martin Kuchař, Rainer Spanagel, Rick E Bernardi

Neuroscience November 1, 2024 DOI: 10.1016/j.neuroscience.2024.09.006 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Preclinical experimental study Peer reviewed
Sample size 82
Population Male and female mice and rats
Intervention Psilocybin
Dose 1.0 mg/kg (mice); 1.0 mg/kg or 2.5 mg/kg (rats)
Duration 8-day self-administration and extinction (mice); 15-day self-administration and extinction (rats)
Topics Addiction Psilocybin
Keywords Addiction treatment Psychedelic research Substance abuse Cocaine dependence Animal studies Cocaine self-administration Mice Rats Reinstatement
Citations 3
Key findings Psilocybin did not attenuate cue-induced reinstatement of cocaine-seeking in either mice or rats.

Abstract

There are currently no pharmacological treatments for cocaine use disorder. Recently there has been a great deal of interest in the potential of psychedelic drugs such as psilocybin to treat psychiatric disorders. Human studies have indicated that a single administration of psilocybin can have long-lasting effects. Few preclinical studies have examined a role for psilocybin in addiction models. The goal of the current study was to determine whether psilocybin would enhance extinction following cocaine self-administration in male and female mice and rats and thus result in an attenuation of cue-induced drug-seeking. In experiments in mice, 16 female and 19 male mice underwent 8d of cocaine self-administration (0.5 mg/kg/infusion) and extinction training. Immediately following extinction trials, mice were injected with vehicle or 1.0 mg/kg psilocybin. Following the conclusion of extinction training, mice were tested for cue-induced reinstatement. In experiments in rats, 24 female and 23 male rats underwent 15d of cocaine self-administration (0.8 mg/kg/infusion) and extinction training. Immediately following extinction trials, rats were injected with vehicle, 1.0 mg/kg psilocybin, or 2.5 mg/kg psilocybin. Following the conclusion of extinction training, rats were tested for cue-induced reinstatement. Psilocybin administered following extinction trials had no effect, as both female and male mice and rats demonstrated significant cue-induced reinstatement. These data suggest that psilocybin is ineffective at altering cocaine-seeking behavior in the paradigm and doses used in the current study. It remains to be seen whether treatment with psilocybin under different conditions may be useful in the long-standing goal of finding pharmacotherapies to treat CUD.

Comparable studies

Other preclinical and animal studies on psilocybin for addiction, most cited first.

Study Year Design Participants
Psychedelics reopen the social reward learning critical period Mice 2023 Experimental study in mice
Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism 2021 Preclinical study
Psilocybin and LSD have no long-lasting effects in an animal model of alcohol relapse Male and female rats 2020 Preclinical animal study
Psilocybin-induced default mode network hypoconnectivity is blunted in alcohol-dependent rats Healthy rats and a rat model of alcohol relapse 2023 Randomized, placebo-controlled crossover pharmaco-fMRI study
Psilocybin prevents reinstatement of alcohol seeking by disrupting the reconsolidation of alcohol-related memories. Male and female Marchigian Sardinian alcohol-preferring (msP) rats 2023 Preclinical experimental study

Citations in the library

Explore topics

By condition and practice